Abstract: 14- or 15-membered-ring macrolide compounds such as clarithromycin, erythromycin B, etc. have a potent antitumor effect on non-small cell lung cancers which are considered the most difficult tumors to be be subjected to surgical operation and chemotherapy, and are useful as a practical therapeutic agent of non-small cell lung cancer.
Type:
Grant
Filed:
October 23, 1996
Date of Patent:
August 18, 1998
Assignee:
Nobuhiro Narita
Inventors:
Nobuhiro Narita, Masayoshi Sawaki, Keiichi Mikasa, Eiji Kita